Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 08:00 am Purchase | 2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | SANDS ARTHUR T | 2,707,896 5.400% | 2,707,896 (New Position) | Filing History |
| 2024-02-13 5:09 pm Purchase | 2023-12-29 | 13G | Nurix Therapeutics, Inc. NRIX | VANGUARD GROUP INC | 2,598,097 5.360% | 2,598,097 (New Position) | Filing History |
| 2024-02-09 1:56 pm Purchase | 2024-02-09 | 13G | Nurix Therapeutics, Inc. NRIX | Wasatch Advisors LP | 2,749,745 5.700% | 211,113 (+8.32%) | Filing History |
| 2024-02-09 1:47 pm Purchase | 2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | MORGAN STANLEY MS | 3,099,198 6.400% | 3,099,198 (New Position) | Filing History |
| 2024-01-29 4:00 pm Purchase | 2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | ARK Investment Management LLC | 3,194,999 6.590% | 3,194,999 (New Position) | Filing History |
| 2024-01-24 2:27 pm Purchase | 2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | BlackRock Inc. BLK | 4,643,736 9.600% | 501,208 (+12.10%) | Filing History |
| 2024-01-23 10:28 am Sale | 2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | STATE STREET CORP STT | 921,322 1.900% | -1,586,665 (-63.26%) | Filing History |
| 2023-02-24 4:13 pm Purchase | 2023-02-16 | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital, LP | 2,717,171 5.750% | 450,602 (+19.88%) | Filing History |
| 2023-02-14 4:21 pm Purchase | 2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Redmile Group, LLC | 4,899,772 9.900% | 1,941,488 (+65.63%) | Filing History |
| 2023-02-14 4:04 pm Sale | 2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Third Rock Ventures III L.P. | 184,544 0.400% | -2,366,213 (-92.77%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Baker Bros. Advisors LP | 4,801,954 9.990% | 2,347,872 (+95.67%) | Filing History |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | PRICE T ROWE ASSOCIATES INC /MD/ | 3,253,736 6.900% | -1,617,348 (-33.20%) | Filing History |
| 2023-02-14 08:50 am Sale | 2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital, LP | 2,266,569 4.810% | -169,595 (-6.96%) | Filing History |
| 2023-02-10 10:54 am Purchase | 2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | STATE STREET CORP STT | 2,507,987 5.320% | 2,507,987 (New Position) | Filing History |
| 2023-02-08 1:07 pm Purchase | 2023-02-08 | 13G | Nurix Therapeutics, Inc. NRIX | Wasatch Advisors LP | 2,538,632 5.400% | 2,538,632 (New Position) | Filing History |
| 2023-01-25 10:36 am Purchase | 2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | BlackRock Inc. BLK | 4,142,528 8.800% | 1,594,667 (+62.59%) | Filing History |
| 2022-06-10 4:02 pm Purchase | 2022-06-01 | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital, LP | 2,436,164 5.190% | 2,436,164 (New Position) | Filing History |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Redmile Group, LLC | 2,958,284 6.600% | 112,159 (+3.94%) | Filing History |
| 2022-02-14 4:57 pm Sale | 2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Third Rock Ventures III L.P. | 2,550,757 5.700% | -2,871,792 (-52.96%) | Filing History |
| 2022-02-14 4:15 pm Purchase | 2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Baker Bros. Advisors LP | 2,454,082 5.500% | 2,454,082 (New Position) | Filing History |